Table 1.
Univariate analysis of the association between refractures within 2 years of post-operative treatment for fragility fractures and surveyed factors in elderly women (N = 784)
| Factor | Refracture (N = 53) | No refracture (N = 731) | χ2/Z | P |
|---|---|---|---|---|
| Age | 78 (74, 88) | 73 (67, 81) | − 5.039 | < 0.001 |
| Residence | ||||
| Rural aera | 20 (37.70%) | 267 (36.50%) | 0.730 | 0.694 |
| Town | 8 (15.10%) | 85 (11.60%) | ||
| City | 25 (47.20%) | 379 (51.80%) | ||
| Inhabiting information | ||||
| Living alone | 20 (37.70%) | 166 (22.70%) | 6.167 | 0.013 |
| Cohabiting with others | 33 (62.30%) | 565 (77.30%) | ||
| Fracture site | ||||
| Hip | 29 (54.70%) | 229 (31.30%) | 14.587 | 0.002 |
| Upper limbs | 6 (11.30%) | 84 (11.50%) | ||
| Lower limbs | 7 (13.20%) | 95 (13.00%) | ||
| Thoracolumbar spine | 11 (20.80%) | 323 (44.20%) | ||
| Bed rest days | 3 (2.00, 6.00%) | 3 (2.00, 3.00%) | − 1.485 | 0.138 |
| Exercise | ||||
| No | 46 (86.80%) | 636 (87.00%) | 0.002 | 0.965 |
| Yes | 7 (13.20%) | 95 (13.00%) | ||
| Walk mode | ||||
| Walk alone | 41 (77.40%) | 628 (85.90%) | 6.577 | 0.037 |
| Bed rest | 8 (15.10%) | 44 (6.00%) | ||
| Relying on a walker/crutches | 4 (7.50%) | 59 (8.10%) | ||
| Drink | ||||
| No | 51 (96.20%) | 650 (88.90%) | 2.787 | 0.095 |
| Yes | 2 (3.80%) | 81 (11.10%) | ||
| Smoke | ||||
| No | 53 (100.00%) | 712 (97.40%) | 1.412 | 0.235 |
| Yes | 0 (0.00%) | 19 (2.60%) | ||
| BMI (kg/m2) | 23.08 (20.15, 25.25) | 23.97 (21.67, 26.76) | − 1.758 | 0.079 |
| Drug time | ||||
| < 1 month | 24 (45.30%) | 422 (57.70%) | 3.545 | 0.170 |
| 1 ~ 3 month | 25 (47.20%) | 253 (34.60%) | ||
| No | 4 (7.50%) | 56 (7.70%) | ||
| Fall risk | ||||
| Low | 7 (13.20%) | 439 (60.10%) | 4.221 | < 0.001 |
| High | 46 (86.80%) | 292 (39.90%) | ||
| Anti-skid | ||||
| No | 44 (83.00%) | 600 (82.10%) | 0.030 | 0.863 |
| Yes | 9 (17.00%) | 131 (17.90%) | ||
| Complication | ||||
| No | 37 (69.80%) | 542 (74.10%) | 0.481 | 0.488 |
| Yes | 16 (30.20%) | 189 (25.90%) | ||
| CerebroVD | ||||
| No | 43 (81.10%) | 584 (79%) | 0.048 | 0.827 |
| Yes | 10 (18.90%) | 147 (20.10%) | ||
| CardioVD | ||||
| No | 26 (49.10%) | 344 (45.70%) | 0.225 | 0.635 |
| Yes | 27 (50.90%) | 397 (54.30%) | ||
| COPD | ||||
| No | 52 (98.10%) | 709 (97.00%) | 0.219 | 0.640 |
| Yes | 1 (1.90%) | 22 (3.00%) | ||
| Anemia | ||||
| No | 50 (94.30%) | 666 (91.10%) | 0.651 | 0.420 |
| Yes | 3 (5.70%) | 65 (8.90%) | ||
| AD | ||||
| No | 53 (100.00%) | 715 (97.80%) | 1184 | 0.276 |
| Yes | 0 (0.00%) | 16 (2.20%) | ||
| Parkinson | ||||
| No | 51 (96.20%) | 731 (100.00%) | 27.655 | < 0.001 |
| Yes | 2 (3.80%) | 0 (0.00%) | ||
| Diabetes | ||||
| No | 41 (77.40%) | 550 (75.20%) | 0.120 | 0.729 |
| Yes | 12 (22.60%) | 181 (24.80%) | ||
| Eye diseases | ||||
| No | 53 (100.00%) | 712 (97.40%) | 1.412 | 0.235 |
| Yes | 0 (0.00%) | 19 (2.60%) | ||
| Rheumatoid arthritis | ||||
| No | 47 (88.70%) | 683 (93.40%) | 1.742 | 0.187 |
| Yes | 6 (11.30%) | 48 (6.60%) | ||
| Hb (g/L) | 111 (103.50, 120.00) | 120 (109.00, 131.00) | − 4.207 | < 0.001 |
| Albumin (g/L) | 35.6 (32.05, 38.00) | 38.2 (35.00, 40.7-) | − 4.349 | < 0.001 |
| ALP (U/L) | 68 (61.00, 88.00) | 79 (66.00, 98.00) | − 2.39 | 0.017 |
| Creatinine (µmol/L) | 58.66 (51.95, 67.61) | 57.85 (50.73, 68.11) | − 0.428 | 0.669 |
| Calcium (mmol/L) | 2.25 (2.15, 2.36) | 2.25 (2.17, 2.30) | − 0.336 | 0.737 |
| Phosphorus (mmol/L) | 1.18 (1.03, 1.29) | 1.13 (1.01, 1.27) | − 0.822 | 0.411 |
| Glucose (mmol/L) | 5.69 (4.98, 6.86) | 5.6 (4.87, 6.89) | − 0.117 | 0.907 |
| Lymphocyte (109/L) | 1.43 (0.86, 2.14) | 1.33 (0.92, 1.81) | − 0.781 | 0.435 |
| Frailty | 10 (9.00, 12.00) | 4 (3.00, 6.00) | − 8.373 | < 0.001 |
| Support | 6 (3.00, 9.00) | 7 (6.00, 12.00) | − 3.341 | 0.001 |